Pharmacokinetics of depot medroxyprogesterone acetate contraception

被引:0
|
作者
Mishell, DR [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT OBSTET & GYNECOL,LOS ANGELES,CA 90089
关键词
depo-medroxyprogesterone acetate; DMPA; contraception; injectable contraception; pharmacokinetics; pharmacodynamics; estradiol; ovulation; fertility; endometrium;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Depot medroxyprogesterone acetate (DMPA) is ail aqueous suspension of 17-acetoxy 6-methyl progestin administered by intramuscular injection for long-term contraception. This highly effective injectable formulation of medroxyprogesterone acetate (MPA) has a prolonged duration of action since the progestin is released slowly from the muscle. MPA is detected in the serum within 30 minutes after an injection of 150 mg. Serum concentrations vary between individual women but generally plateau at about 1.0 ng/mL for about three months, after which there is a gradual decline. In some women, MPA can be detected in the serum for as long as nine months after a single injection of 150 mg. The circulating MPA initially inhibits the midcycle leutinizing hormone (LH) peak, but LH and follicle stimulating hormone (FSH) levels remain in the range of those for the luteal phase of a pretreatment control cycle. Since ovulation is inhibited, serum progesterone levels remain low (< 0.4 ng/mL) for several months following an injection of DMPA. When MPA levels fall below 0.1 ng/mL, ovulation resumes. Thus, return to fertility is delayed for several months if a woman wishes to conceive after receiving one or move injections of DMPA. Following an injection of DMPA, serum estradiol levels initially are in the early to midfollicular phase range (mean approximately 50 pg/nL). Serum estradiol levels begin to rise about four months after a single injection when MPA levels fall below 0.5 ng/mL. For women who have used DMPA for several years, serum estradiol levels range between 10 and 92 pg/mL, with mean levels of about 40 pg/mL. Despite these low levels of estradiol, hot flushes are a rare event, and the vaginal epithelium remains moist and well rugated. Women using DMPA for several years do not observe a change in breast size. DMPA causes the endometrium to become atrophic, with small, straight endometrial glands and decidualized stroma. The cervical mucus remains thick and viscid. DMPA is a very effective form of contraception because of its multiple mechanisms of action and slow release into the circulation.
引用
收藏
页码:381 / 390
页数:10
相关论文
共 50 条
  • [31] Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception
    Cundy, T
    Cornish, J
    Roberts, H
    Reid, IR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (05) : 978 - 983
  • [32] The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women
    Scholes, D
    LaCroix, AZ
    Ichikawa, LE
    Barlow, WE
    Ott, SM
    CONTRACEPTION, 2004, 69 (02) : 99 - 104
  • [34] A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females
    Bonny, Andrea E.
    Lange, Hannah L. H.
    Rogers, Lynette K.
    Gothard, Dave M.
    Reed, Michael D.
    CONTRACEPTION, 2014, 89 (05) : 357 - 360
  • [35] Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion
    Krashin, Jamie W.
    Stuart, Gretchen S.
    Garrett, Joanne
    Spector, Hannah
    Bryant, Amy G.
    Charm, Samantha
    Morse, Jessica E.
    OBSTETRICS AND GYNECOLOGY, 2017, 130 (01): : 109 - 117
  • [36] Diabetes and depot medroxyprogesterone contraception in Navajo women
    Kim, C
    Seidel, KW
    Begier, EA
    Kwok, YS
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) : 1766 - 1771
  • [37] Reasons for discontinuation of depot medroxyprogesterone acetate
    Hajikazemi, E
    Nikpour, S
    Haghani, H
    RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 315 - 318
  • [39] Depot-medroxyprogesterone acetate: an update
    Bakry, Sayed
    Merhi, Zaher O.
    Scalise, Trudy J.
    Mahmoud, Mohamad S.
    Fadiel, Ahmed
    Naftolin, Frederick
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2008, 278 (01) : 1 - 12
  • [40] Depot-medroxyprogesterone acetate: an update
    Sayed Bakry
    Zaher O. Merhi
    Trudy J. Scalise
    Mohamad S. Mahmoud
    Ahmed Fadiel
    Frederick Naftolin
    Archives of Gynecology and Obstetrics, 2008, 278 : 1 - 12